Clean water regs threaten drug supply in EU, industry says

28 October 2022
europe_flag_big

The pharmaceutical industry in Europe has questioned measures aimed at improving the way wastewater is treated by countries within the European Union.

In a bid to ensure the cleanliness of water in the region, the European Commission has proposed to charge medicines in the Urban Wastewater Treatment Directive.

In a statement, Brussels-based trade bodies The European Federation of Pharmaceutical Industries and Associations (EFPIA) and Medicines for Europe said the measure would “ultimately jeopardize patient access to medicines.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical